GLENVIEW, Ill.--(BUSINESS WIRE)--Jul. 26, 2012--
Mead Johnson Nutrition Company (NYSE: MJN) announced today its financial
results for the second quarter ended June 30, 2012.
-
Net sales of $1,012.3 million in the quarter were up 9 percent versus
the second quarter of 2011. Excluding the unfavorable impact of
foreign exchange, sales increased 11 percent.
-
GAAP net earnings of $0.81 per diluted share for the second quarter of
2012 were up 27 percent from $0.64 per diluted share a year ago.
-
Non-GAAP(1) net earnings of $0.83 per diluted share
increased 15 percent from $0.72 per diluted share for 2011.
-
The sales increase was driven by the Asia/Latin America segment with
constant dollar growth of 16 percent with a majority of the markets
achieving double-digit gains. For the North America/Europe segment,
sales were flat excluding the unfavorable impact of foreign exchange.
-
Earnings benefited from strong sales growth, reduced IT and other
separation expenses following the prior year SAP implementation,
balance sheet re-measurement gains from foreign exchange and a
lower effective tax rate. These benefits were partially offset by
lower gross margins largely driven by higher commodity costs, higher
demand-generation investments and the recognition of pension
settlement expense.
-
Full-year non-GAAP EPS is expected to be in the range of $3.04 to
$3.14. Including specified items estimated at $0.09 per share,
full-year GAAP EPS guidance is $2.95 to $3.05.
(1)
See “Non-GAAP Financial Measures” and the reconciliation of GAAP and
non-GAAP results included in this release.
“Our sales and earnings growth continued to be strong in the second
quarter,” said Chief Executive Officer Stephen W. Golsby. “Sales growth
was broad-based across Asia and Latin America and included the first
full-quarter from our Argentine acquisition. The majority of markets in
this segment reported double-digit growth on a constant dollar basis.
China/Hong Kong continued to deliver strong sales growth; however, we
expect lower growth in the second half of the year in light of recent
data indicating both a slowdown in the China category and a decline in
Mead Johnson’s market share. In the North America/Europe segment, we saw
a significant improvement in the U.S. business compared to the first
quarter. We are particularly encouraged by strengthening market share
amongst three-month old babies who will age into a higher consumption
period during the second half. We increased global demand-generation
investments to drive sustainable growth while benefiting from lower
general and administrative spending, including significantly lower IT
and other separation expenses. While mindful of the challenging economic
environment and slower growth in China, we remain on track to deliver
strong earnings growth in 2012.”
Second Quarter Results
Net sales for the second quarter totaled $1,012.3 million, up 9 percent
from $932.0 million a year ago. Sales benefited 8 percent from price, 3
percent from volume, reduced by 2 percent from foreign exchange.
Earnings before interest and income taxes (EBIT) for the second quarter
totaled $248.3 million, up 22 percent from $203.7 million a year
earlier. The EBIT increase was driven by sales growth, lower IT and
other separation expenses following the 2011 SAP implementation,
favorable balance sheet re-measurement gains from foreign exchange and
lower performance-based compensation accruals. These factors were
partially offset by lower gross margins, higher demand-generation
investments and the earlier recognition of pension settlement expense
compared to the prior year.
Gross margin was down 150 basis points versus the second quarter of
2011. The decrease was from higher commodity costs and unfavorable
manufacturing variances, largely attributed to lower production volume
in our North America/Europe segment, partially offset by higher pricing
and productivity gains. Investment spending for advertising and
promotion, sales force expansion in growth markets and research and
development increased compared to the prior year. Foreign currency
balance sheet re-measurement gains, mainly at our European manufacturing
entity, were largely offset by pension settlement expense recognized in
the second quarter of 2012 compared to the fourth quarter of 2011. The
effective tax rate for the quarter was 25.9 percent versus 29.6 percent
a year ago. The decrease in the effective tax rate was attributable to a
change in geographic earnings mix and to higher manufacturing incentives.
Net earnings attributable to shareholders for the second quarter of 2012
totaled $165.8 million, or $0.81 per diluted share, compared with $132.1
million, or $0.64 per diluted share, a 27 percent increase from the
prior-year quarter. In addition to EBIT increases, the second quarter of
2012 benefited from a lower effective tax rate.
On a non-GAAP basis, which excludes specified items, the net earnings
attributable to shareholders totaled $171.2 million, or $0.83 per
diluted share, compared with $148.7 million, or $0.72 per diluted share,
a 15 percent increase from the same quarter a year ago.
Second Quarter Segment Results
The Asia/Latin America segment delivered net sales of $695.2 million for
the second quarter of 2012, up 14 percent from $611.6 million in 2011.
Sales benefited 9 percent from price, 7 percent from volume, reduced by
2 percent from foreign exchange. The segment benefited from the first
full quarter of sales following the March 2012 acquisition of an 80
percent equity interest in Argentina’s leading infant formula and
children’s nutrition business. EBIT totaled $237.5 million, up 13
percent compared with $209.8 million for the year-ago quarter. EBIT
increased from sales growth partially offset by higher demand-generation
investment spending.
The North America/Europe segment reported net sales of $317.1 million
for the second quarter of 2012, down 1 percent from $320.4 million in
2011. Sales benefited 5 percent from price, offset by a 5 percent
decline in volume and a 1 percent reduction from foreign exchange. The
volume decrease reflected lower U.S. market share, as well as lower
category consumption and births. The U.S. market share was lower in
comparison to the prior year when we benefited from a competitor’s
recall and due to the current year impact of the unfounded media reports
in December 2011 of alleged product contamination. EBIT for the segment
totaled $74.6 million, down 14 percent compared with $86.4 million for
the year-ago quarter. The decline in EBIT was primarily due to higher
commodity costs and unfavorable manufacturing variances attributed to
lower production volumes in the U.S.
Corporate and Other expenses decreased from lower IT and separation
costs, the elimination of duplicate shared service costs during the SAP
implementation completed in late 2011, foreign currency balance sheet
re-measurement gains and lower performance-based compensation accruals.
These factors were partially offset by the recognition of pension
settlement expense. Similar pension settlement expense was recognized in
the fourth quarter of the prior year.
Six-Month Results
Net sales for the six months ended June 30, 2012, totaled $1,998.9
million, up 9 percent from $1,831.8 million a year ago. Sales benefited
6 percent from price and 4 percent from volume, reduced by 1 percent
from foreign exchange.
Gross margin was down 190 basis points versus the first six months of
2011 due to higher dairy costs in the North America/Europe segment.
Manufacturing variances were also unfavorable, largely attributed to
lower production volume in our North America/Europe segment. These
increased costs were partially offset by higher pricing as well as
productivity gains.
EBIT for the first half of 2012 totaled $497.1 million, up 17 percent
from $426.3 million a year earlier. The EBIT increase was driven by
sales growth, lower expenses related to the SAP implementation completed
in 2011 and the elimination of duplicate costs from the overlap in
shared service providers and favorable foreign exchange. These factors
were partially offset by lower gross margins, higher demand-generation
spending and the timing of pension settlement expense.
The effective tax rate for the six months ended June 30, 2012 was 26.7
percent versus 29.2 percent a year ago. The decrease in the effective
tax rate was primarily attributed to a change in geographic earnings mix
and to higher manufacturing incentives.
Net earnings attributable to shareholders for the first half of 2012
totaled $330.0 million, or $1.61 per diluted share, compared with $278.2
million, or $1.35 per diluted share, a 19 percent increase from the
prior-year period. Net earnings for the six months ended June 30, 2012
benefited from the EBIT increase and a lower effective tax rate.
On a non-GAAP basis, which excludes specified items, net earnings
attributable to shareholders totaled $338.6 million, or $1.65 per
diluted share, for the first half of 2012, compared with $305.5 million,
or $1.48 per diluted share, an 11 percent increase from the same period
a year ago.
Six-Month Segment Results
The Asia/Latin America segment had net sales of $1,396.5 million for the
first half of 2012, up 18 percent from $1,188.5 million in 2011. Sales
benefited 11 percent from volume and 7 percent from price. The majority
of the markets in the segment delivered double-digit constant dollar
sales growth driven both by price increases and higher volumes. Sales
also benefited from the Argentine acquisition which closed in March
2012. EBIT for the segment totaled $516.5 million, up 21 percent
compared with $426.6 million for the year-ago period. The EBIT increase
was primarily related to sales growth and improved gross margin,
partially offset by increased demand-generation investments.
The North America/Europe segment reported net sales of $602.4 million
for the first half of 2012, down 6 percent compared with $643.3 million
in 2011. Sales benefited 4 percent from price, offset by a 9 percent
decline in volume and a 1 percent reduction from foreign exchange.
Segment sales declined from lower U.S. market share, as well as lower
category consumption and births. Market share was lower in comparison to
the prior year when we benefitted from a competitor’s recall and due to
the current year impact of the unfounded media reports in December 2011
of alleged product contamination. EBIT totaled $108.3 million, down 40
percent compared with $179.3 million in the same period a year ago. The
EBIT decrease was attributed to lower sales, higher dairy costs and
unfavorable manufacturing variances.
Corporate and Other expenses decreased from lower IT and separation
costs, foreign currency balance sheet re-measurement gains and the
elimination of duplicate shared service costs incurred during the SAP
implementation project completed in 2011, partially offset by pension
settlement expense triggered earlier than in the prior year.
Outlook for 2012
“We are pleased with our strong second quarter results; however, we
anticipate slower growth in the second half of 2012. Annual constant
dollar sales are now expected to grow in the range of 8 to 9 percent
compared to the 9 to 11 percent sales growth anticipated earlier in the
year. Slower growth in China is partially offset by an improvement in
our U.S. business. Our full-year non-GAAP earnings are estimated in the
range of $3.04 to $3.14 per share,” Mr. Golsby noted. “Lower sales
growth in China is partially offset by favorable foreign currency
balance sheet re-measurement gains and a lower sustainable effective tax
rate. We estimate the effective tax rate will be in the range of 26 to
27 percent. While expecting weaker third quarter growth, we remain
confident that we will exit the year with improved market share in China
and that our strategies and execution will deliver strong earnings
performance.”
Conference Call Scheduled
The company will host a conference call at 8:30 a.m. CDT today during
which company executives will review second quarter financial results
and respond to questions from analysts and investors. The call will be
broadcast over the Internet at meadjohnson.com.
To listen to the call, visit the website at least 15 minutes before the
call and click on the “Investors” tab. Security analysts and investors
wishing to participate by telephone should call (866) 713-8310, pass
code: Mead Johnson. Callers outside of North America should call
+1-617-597-5308 to be connected. A replay of the conference call will be
available through midnight CDT Thursday, August 2, 2012, by calling
(888) 286-8010 or outside of North America by calling +1-617-801-6888,
pass code: 94089899. The replay will also be available at meadjohnson.com.
Forward-Looking Statements
Certain statements in this news release are forward looking as defined
in the Private Securities Litigation Reform Act of 1995. These
statements, which are identified by words such as “expects,” “intends”
and “believes,” involve certain risks, uncertainties and assumptions
that may cause actual results to differ materially from expectations as
of the date of this news release. These risks include, but are not
limited to: (1) the ability to sustain brand strength, particularly the
“Enfa” family of brands; (2) the effect on the company’s reputation of
real or perceived quality issues; (3) the adverse effect of commodity
costs; (4) increased competition from branded, private label, store and
economy-branded products; (5) the effect of an economic downturn on
consumers’ purchasing behavior and customers’ ability to pay for
product; (6) inventory reductions by customers; (7) the adverse effect
of changes in foreign currency exchange rates; (8) the effect of changes
in economic, political and social conditions in the markets where we
operate; (9) legislative, regulatory or judicial action that may
adversely affect the company’s ability to advertise its products or
maintain product margins; (10) the possibility of changes in the Women,
Infant and Children (WIC) program, or increases in levels of
participation in WIC; and (11) the ability to develop and market new,
innovative products. For additional information on these and other
factors, see the risk factors identified in the company’s periodic
reports, including the annual report on Form 10-K for 2011, quarterly
reports on Form 10-Q and current reports on Form 8-K, filed with, or
furnished to, the Securities and Exchange Commission, available upon
request or at meadjohnson.com.
The company undertakes no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future events or otherwise.
About Mead Johnson
Mead Johnson, a global leader in pediatric nutrition, develops,
manufactures, markets and distributes more than 70 products in over 50
markets worldwide. The company’s mission is to nourish the world’s
children for the best start in life. The Mead Johnson name has been
associated with science-based pediatric nutrition products for over 100
years. The company’s “Enfa” family of brands, including Enfamil®
infant formula, is the world’s leading brand franchise in pediatric
nutrition. For more information, visit meadjohnson.com.
|
|
|
|
|
|
|
INTERIM CONSOLIDATED FINANCIAL STATEMENTS
|
|
MEAD JOHNSON NUTRITION COMPANY
|
|
CONSOLIDATED STATEMENTS OF EARNINGS
|
|
(Dollars in millions, except per share data)
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
NET SALES
|
|
$
|
1,012.3
|
|
|
$
|
932.0
|
|
|
$
|
1,998.9
|
|
$
|
1,831.8
|
|
Cost of Products Sold
|
|
|
372.3
|
|
|
|
329.1
|
|
|
|
745.8
|
|
|
649.1
|
|
GROSS PROFIT
|
|
|
640.0
|
|
|
|
602.9
|
|
|
|
1,253.1
|
|
|
1,182.7
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
Selling, General and Administrative
|
|
|
221.1
|
|
|
|
246.6
|
|
|
|
431.5
|
|
|
460.0
|
|
Advertising and Promotion
|
|
|
148.7
|
|
|
|
131.9
|
|
|
|
274.5
|
|
|
243.2
|
|
Research and Development
|
|
|
23.6
|
|
|
|
22.2
|
|
|
|
46.1
|
|
|
41.5
|
|
Other Expenses/(Income)—net
|
|
|
(1.7
|
)
|
|
|
(1.5
|
)
|
|
|
3.9
|
|
|
11.7
|
|
EARNINGS BEFORE INTEREST AND INCOME TAXES
|
|
|
248.3
|
|
|
|
203.7
|
|
|
|
497.1
|
|
|
426.3
|
|
|
|
|
|
|
|
|
|
|
|
Interest Expense—net
|
|
|
17.6
|
|
|
|
12.2
|
|
|
|
32.1
|
|
|
25.3
|
|
EARNINGS BEFORE INCOME TAXES
|
|
|
230.7
|
|
|
|
191.5
|
|
|
|
465.0
|
|
|
401.0
|
|
|
|
|
|
|
|
|
|
|
|
Provision for Income Taxes
|
|
|
59.6
|
|
|
|
56.6
|
|
|
|
124.1
|
|
|
117.2
|
|
NET EARNINGS
|
|
|
171.1
|
|
|
|
134.9
|
|
|
|
340.9
|
|
|
283.8
|
|
Less Net Earnings Attributable to Noncontrolling Interests
|
|
|
5.3
|
|
|
|
2.8
|
|
|
|
10.9
|
|
|
5.6
|
|
NET EARNINGS ATTRIBUTABLE TO SHAREHOLDERS
|
|
$
|
165.8
|
|
|
$
|
132.1
|
|
|
$
|
330.0
|
|
$
|
278.2
|
|
Earnings per Share—Basic
|
|
|
|
|
|
|
|
|
|
Net Earnings Attributable to Shareholders
|
|
$
|
0.81
|
|
|
$
|
0.64
|
|
|
$
|
1.61
|
|
$
|
1.36
|
|
Earnings per Share—Diluted
|
|
|
|
|
|
|
|
|
|
Net Earnings Attributable to Shareholders
|
|
$
|
0.81
|
|
|
$
|
0.64
|
|
|
$
|
1.61
|
|
$
|
1.35
|
|
|
|
|
|
|
|
|
|
|
|
Dividends Declared per Share
|
|
$
|
0.30
|
|
|
$
|
0.26
|
|
|
$
|
0.60
|
|
$
|
0.52
|
|
|
|
|
|
|
|
MEAD JOHNSON NUTRITION COMPANY
|
|
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
|
|
(Dollars in millions)
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
NET EARNINGS
|
|
$
|
171.1
|
|
|
$
|
134.9
|
|
|
$
|
340.9
|
|
|
$
|
283.8
|
|
|
OTHER COMPREHENSIVE INCOME/(LOSSES)
|
|
|
|
|
|
|
|
|
|
Foreign Currency Translation Adjustments
|
|
|
|
|
|
|
|
|
|
Translation Adjustments
|
|
|
(52.7
|
)
|
|
|
3.9
|
|
|
|
(29.8
|
)
|
|
|
36.8
|
|
|
Tax Benefit/(Expense)
|
|
|
11.7
|
|
|
|
(1.2
|
)
|
|
|
5.3
|
|
|
|
(5.3
|
)
|
|
Deferred Gains/(Losses) on Derivatives Qualifying as Hedges
|
|
|
|
|
|
|
|
|
|
Deferred Gains/(Losses) on Derivatives Qualifying as Hedges for the
Period
|
|
|
2.3
|
|
|
|
(2.1
|
)
|
|
|
(4.1
|
)
|
|
|
(5.8
|
)
|
|
Reclassification Adjustment for (Gains)/Losses Included in Net Income
|
|
|
0.5
|
|
|
|
2.0
|
|
|
|
(0.5
|
)
|
|
|
3.4
|
|
|
Tax Benefit/(Expense)
|
|
|
(0.8
|
)
|
|
|
—
|
|
|
|
1.4
|
|
|
|
0.7
|
|
|
Pension and Other Post Retirement Benefits
|
|
|
|
|
|
|
|
|
|
Deferred Gains/(Losses) on Pension and Other Post Retirement Benefits
|
|
|
0.1
|
|
|
|
0.2
|
|
|
|
—
|
|
|
|
—
|
|
|
Reclassification Adjustment for (Gains)/Losses Included in Net Income
|
|
|
10.7
|
|
|
|
1.3
|
|
|
|
12.5
|
|
|
|
2.5
|
|
|
Tax Benefit/(Expense)
|
|
|
(4.0
|
)
|
|
|
(0.4
|
)
|
|
|
(3.2
|
)
|
|
|
(2.7
|
)
|
|
OTHER COMPREHENSIVE INCOME
|
|
|
(32.2
|
)
|
|
|
3.7
|
|
|
|
(18.4
|
)
|
|
|
29.6
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPREHENSIVE INCOME
|
|
|
138.9
|
|
|
|
138.6
|
|
|
|
322.5
|
|
|
|
313.4
|
|
|
|
|
|
|
|
|
|
|
|
|
Less Comprehensive Income Attributable to Noncontrolling Interests
|
|
|
5.3
|
|
|
|
2.8
|
|
|
|
10.9
|
|
|
|
5.8
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPREHENSIVE INCOME ATTRIBUTABLE TO SHAREHOLDERS
|
|
$
|
133.6
|
|
|
$
|
135.8
|
|
|
$
|
311.6
|
|
|
$
|
307.6
|
|
|
|
|
|
|
|
|
MEAD JOHNSON NUTRITION COMPANY
|
|
CONSOLIDATED BALANCE SHEETS
|
|
(Dollars and shares in millions, except per share data)
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
December 31,
|
|
|
|
2012
|
|
2011
|
|
ASSETS
|
|
|
|
|
|
CURRENT ASSETS:
|
|
|
|
|
|
Cash and Cash Equivalents
|
|
$
|
787.3
|
|
|
$
|
840.3
|
|
|
Receivables—net of allowances of $6.7 and $6.3, respectively
|
|
|
366.2
|
|
|
|
352.6
|
|
|
Inventories
|
|
|
494.5
|
|
|
|
534.9
|
|
|
Deferred Income Taxes—net of valuation allowance
|
|
|
115.4
|
|
|
|
118.5
|
|
|
Income Taxes Receivable
|
|
|
6.2
|
|
|
|
3.3
|
|
|
Prepaid Expenses and Other Assets
|
|
|
58.1
|
|
|
|
40.1
|
|
|
Total Current Assets
|
|
|
1,827.7
|
|
|
|
1,889.7
|
|
|
Property, Plant, and Equipment—net
|
|
|
579.8
|
|
|
|
576.1
|
|
|
Goodwill
|
|
|
283.9
|
|
|
|
117.5
|
|
|
Other Intangible Assets—net
|
|
|
143.5
|
|
|
|
91.6
|
|
|
Deferred Income Taxes—net of valuation allowance
|
|
|
20.1
|
|
|
|
16.5
|
|
|
Other Assets
|
|
|
104.8
|
|
|
|
75.4
|
|
|
TOTAL
|
|
$
|
2,959.8
|
|
|
$
|
2,766.8
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY/(DEFICIT)
|
|
|
|
|
|
CURRENT LIABILITIES:
|
|
|
|
|
|
Accounts Payable
|
|
$
|
441.4
|
|
|
$
|
488.1
|
|
|
Dividends Payable
|
|
|
61.6
|
|
|
|
53.3
|
|
|
Note Payable
|
|
|
83.7
|
|
|
|
—
|
|
|
Accrued Expenses
|
|
|
184.0
|
|
|
|
229.0
|
|
|
Accrued Rebates and Returns
|
|
|
308.2
|
|
|
|
300.1
|
|
|
Deferred Income—current
|
|
|
2.7
|
|
|
|
47.0
|
|
|
Income Taxes—payable and deferred
|
|
|
61.0
|
|
|
|
82.6
|
|
|
Total Current Liabilities
|
|
|
1,142.6
|
|
|
|
1,200.1
|
|
|
Long-Term Debt
|
|
|
1,527.5
|
|
|
|
1,531.9
|
|
|
Deferred Income Taxes—noncurrent
|
|
|
20.6
|
|
|
|
5.2
|
|
|
Pension, Post Retirement and Post Employment Liabilities
|
|
|
157.2
|
|
|
|
157.2
|
|
|
Other Liabilities
|
|
|
77.8
|
|
|
|
40.4
|
|
|
Total Liabilities
|
|
|
2,925.7
|
|
|
|
2,934.8
|
|
|
COMMITMENTS AND CONTINGENCIES
|
|
|
|
|
|
|
|
|
|
|
|
REDEEMABLE NONCONTROLLING INTEREST
|
|
|
32.3
|
|
|
|
—
|
|
|
|
|
|
|
|
|
EQUITY/(DEFICIT)
|
|
|
|
|
|
Shareholders’ Equity
|
|
|
|
|
|
Common Stock, $0.01 par value: 3,000 authorized, 205.9 and 205.1
issued, respectively
|
|
|
2.1
|
|
|
|
2.1
|
|
|
Additional Paid-in/(Distributed) Capital
|
|
|
(695.4
|
)
|
|
|
(728.4
|
)
|
|
Retained Earnings
|
|
|
975.9
|
|
|
|
770.0
|
|
|
Treasury Stock—at cost
|
|
|
(148.5
|
)
|
|
|
(89.7
|
)
|
|
Accumulated Other Comprehensive Income/(Loss)
|
|
|
(151.5
|
)
|
|
|
(133.1
|
)
|
|
Total Shareholders’ Equity/(Deficit)
|
|
|
(17.4
|
)
|
|
|
(179.1
|
)
|
|
Noncontrolling Interests
|
|
|
19.2
|
|
|
|
11.1
|
|
|
Total Equity/(Deficit)
|
|
|
1.8
|
|
|
|
(168.0
|
)
|
|
TOTAL
|
|
$
|
2,959.8
|
|
|
$
|
2,766.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MEAD JOHNSON NUTRITION COMPANY
|
|
CONSOLIDATED STATEMENTS OF EQUITY/(DEFICIT)
|
|
AND REDEEMABLE NONCONTROLLING INTEREST
|
|
(Dollars in millions)
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
Redeemable
|
|
|
|
|
|
Paid-in
|
|
|
|
|
|
Other
|
|
Non-
|
|
|
|
Non-
|
|
|
|
Common
|
|
(Distributed)
|
|
Retained
|
|
Treasury
|
|
Comprehensive
|
|
controlling
|
|
Total Equity/
|
|
controlling
|
|
|
|
Stock
|
|
Capital
|
|
Earnings
|
|
Stock
|
|
Income (Loss)
|
|
Interests
|
|
(Deficit)
|
|
Interest
|
|
BALANCE January 1, 2011
|
|
$
|
2.0
|
|
$
|
(775.6
|
)
|
|
$
|
474.0
|
|
|
$
|
(3.2
|
)
|
|
$
|
(64.6
|
)
|
|
$
|
9.1
|
|
|
$
|
(358.3
|
)
|
|
$
|
—
|
|
Stock-based Compensation Awards
|
|
|
|
|
23.7
|
|
|
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
23.6
|
|
|
|
|
Treasury Stock Acquired
|
|
|
|
|
|
|
|
|
(54.1
|
)
|
|
|
|
|
|
|
(54.1
|
)
|
|
|
|
Distributions to Noncontrolling Interests
|
|
|
|
|
|
|
|
|
|
|
|
|
(2.7
|
)
|
|
|
(2.7
|
)
|
|
|
|
Cash Dividends Declared
|
|
|
|
|
|
|
(106.4
|
)
|
|
|
|
|
|
|
|
|
(106.4
|
)
|
|
|
|
Net Earnings
|
|
|
|
|
|
|
278.2
|
|
|
|
|
|
|
|
5.6
|
|
|
|
283.8
|
|
|
|
|
Other Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
29.4
|
|
|
|
0.2
|
|
|
|
29.6
|
|
|
|
|
BALANCE June 30, 2011
|
|
$
|
2.0
|
|
$
|
(751.9
|
)
|
|
$
|
645.8
|
|
|
$
|
(57.4
|
)
|
|
$
|
(35.2
|
)
|
|
$
|
12.2
|
|
|
$
|
(184.5
|
)
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE January 1, 2012
|
|
$
|
2.1
|
|
$
|
(728.4
|
)
|
|
$
|
770.0
|
|
|
$
|
(89.7
|
)
|
|
$
|
(133.1
|
)
|
|
$
|
11.1
|
|
|
$
|
(168.0
|
)
|
|
$
|
—
|
|
Stock-based Compensation Awards
|
|
|
|
|
33.0
|
|
|
|
|
|
(14.8
|
)
|
|
|
|
|
|
|
18.2
|
|
|
|
|
Treasury Stock Acquired
|
|
|
|
|
|
|
|
|
(44.0
|
)
|
|
|
|
|
|
|
(44.0
|
)
|
|
|
|
Acquisition
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
|
30.2
|
|
Distributions to Noncontrolling Interests
|
|
|
|
|
|
|
|
|
|
|
|
|
(2.2
|
)
|
|
|
(2.2
|
)
|
|
|
|
Cash Dividends Declared
|
|
|
|
|
|
|
(122.6
|
)
|
|
|
|
|
|
|
|
|
(122.6
|
)
|
|
|
|
Net Earnings
|
|
|
|
|
|
|
330.0
|
|
|
|
|
|
|
|
10.3
|
|
|
|
340.3
|
|
|
|
0.6
|
|
Redeemable Noncontrolling Interest Accretion
|
|
|
|
|
|
|
(1.5
|
)
|
|
|
|
|
|
|
|
|
(1.5
|
)
|
|
|
1.5
|
|
Other Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
(18.4
|
)
|
|
|
|
|
(18.4
|
)
|
|
|
|
BALANCE June 30, 2012
|
|
$
|
2.1
|
|
$
|
(695.4
|
)
|
|
$
|
975.9
|
|
|
$
|
(148.5
|
)
|
|
$
|
(151.5
|
)
|
|
$
|
19.2
|
|
|
$
|
1.8
|
|
|
$
|
32.3
|
|
|
|
|
|
MEAD JOHNSON NUTRITION COMPANY
|
|
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
(Dollars in millions)
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
Six Months Ended June 30,
|
|
|
|
2012
|
|
2011
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
Net Earnings
|
|
$
|
340.9
|
|
|
$
|
283.8
|
|
|
Adjustments to Reconcile Net Earnings to Net Cash Provided by
Operating Activities:
|
|
|
|
|
|
Depreciation and Amortization
|
|
|
37.6
|
|
|
|
37.6
|
|
|
Other
|
|
|
29.9
|
|
|
|
21.5
|
|
|
Changes in Assets and Liabilities
|
|
|
(137.6
|
)
|
|
|
(48.8
|
)
|
|
Pension and Other Post Retirement Benefits Contributions
|
|
|
(3.6
|
)
|
|
|
(2.4
|
)
|
|
Net Cash Provided by Operating Activities
|
|
|
267.2
|
|
|
|
291.7
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
Payments for Capital Expenditures
|
|
|
(50.0
|
)
|
|
|
(49.5
|
)
|
|
Proceeds from Sale of Property, Plant and Equipment
|
|
|
0.8
|
|
|
|
0.6
|
|
|
Acquisition
|
|
|
(106.1
|
)
|
|
|
—
|
|
|
Net Cash Used in Investing Activities
|
|
|
(155.3
|
)
|
|
|
(48.9
|
)
|
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
Proceeds from Short-term Borrowings
|
|
|
180.0
|
|
|
|
0.9
|
|
|
Repayments of Short-term Borrowings
|
|
|
(180.0
|
)
|
|
|
(2.1
|
)
|
|
Payments of Dividends
|
|
|
(114.3
|
)
|
|
|
(99.3
|
)
|
|
Stock-based-compensation-related Proceeds and Excess Tax Benefits
|
|
|
18.8
|
|
|
|
2.5
|
|
|
Purchases of Treasury Stock
|
|
|
(58.8
|
)
|
|
|
(55.4
|
)
|
|
Distributions to Noncontrolling Interests
|
|
|
(2.2
|
)
|
|
|
(2.7
|
)
|
|
Net Cash Used in Financing Activities
|
|
|
(156.5
|
)
|
|
|
(156.1
|
)
|
|
Effects of Changes in Exchange Rates on Cash and Cash Equivalents
|
|
|
(8.4
|
)
|
|
|
21.4
|
|
|
NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS
|
|
|
(53.0
|
)
|
|
|
108.1
|
|
|
CASH AND CASH EQUIVALENTS:
|
|
|
|
|
|
Beginning of Period
|
|
|
840.3
|
|
|
|
595.6
|
|
|
End of Period
|
|
$
|
787.3
|
|
|
$
|
703.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MEAD JOHNSON NUTRITION COMPANY
|
|
SUPPLEMENTAL FINANCIAL INFORMATION
|
|
(Dollars in millions)
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
% Change Due to
|
|
|
|
Three Months Ended June 30,
|
|
|
|
|
|
|
|
Foreign
|
|
|
|
2012
|
|
2011
|
|
% Change
|
|
Volume
|
|
Price
|
|
Exchange
|
|
Net Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asia/Latin America
|
|
$
|
695.2
|
|
|
$
|
611.6
|
|
|
14
|
%
|
|
7
|
%
|
|
9
|
%
|
|
-2
|
%
|
|
North America/Europe
|
|
|
317.1
|
|
|
|
320.4
|
|
|
-1
|
%
|
|
-5
|
%
|
|
5
|
%
|
|
-1
|
%
|
|
Total
|
|
$
|
1,012.3
|
|
|
$
|
932.0
|
|
|
9
|
%
|
|
3
|
%
|
|
8
|
%
|
|
-2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Before Interest and Income Taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asia/Latin America
|
|
$
|
237.5
|
|
|
$
|
209.8
|
|
|
13
|
%
|
|
|
|
|
|
|
|
North America/Europe
|
|
|
74.6
|
|
|
|
86.4
|
|
|
-14
|
%
|
|
|
|
|
|
|
|
Corporate and Other
|
|
|
(63.8
|
)
|
|
|
(92.5
|
)
|
|
31
|
%
|
|
|
|
|
|
|
|
Total
|
|
$
|
248.3
|
|
|
$
|
203.7
|
|
|
22
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Change Due to
|
|
|
|
Six Months Ended June 30,
|
|
|
|
|
|
|
|
Foreign
|
|
|
|
2012
|
|
2011
|
|
% Change
|
|
Volume
|
|
Price
|
|
Exchange
|
|
Net Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asia/Latin America
|
|
$
|
1,396.5
|
|
|
$
|
1,188.5
|
|
|
18
|
%
|
|
11
|
%
|
|
7
|
%
|
|
0
|
%
|
|
North America/Europe
|
|
|
602.4
|
|
|
|
643.3
|
|
|
-6
|
%
|
|
-9
|
%
|
|
4
|
%
|
|
-1
|
%
|
|
Total
|
|
$
|
1,998.9
|
|
|
$
|
1,831.8
|
|
|
9
|
%
|
|
4
|
%
|
|
6
|
%
|
|
-1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Before Interest and Income Taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asia/Latin America
|
|
$
|
516.5
|
|
|
$
|
426.6
|
|
|
21
|
%
|
|
|
|
|
|
|
|
North America/Europe
|
|
|
108.3
|
|
|
|
179.3
|
|
|
-40
|
%
|
|
|
|
|
|
|
|
Corporate and Other
|
|
|
(127.7
|
)
|
|
|
(179.6
|
)
|
|
29
|
%
|
|
|
|
|
|
|
|
Total
|
|
$
|
497.1
|
|
|
$
|
426.3
|
|
|
17
|
%
|
|
|
|
|
|
|
Non-GAAP Financial Measures
This news release contains non-GAAP financial measures, including
non-GAAP EBIT, earnings and earnings per share information. The items
included in GAAP measures, but excluded for the purpose of determining
non-GAAP EBIT, earnings and earnings per share, are IT separation and
other costs (Specified Items). In addition, other items include the tax
impact on Specified Items. Non-GAAP EBIT, earnings and earnings per
share information adjusted for these items is an indication of the
company’s underlying operating results and intended to enhance an
investor’s overall understanding of the company’s financial performance.
In addition, this information is among the primary indicators the
company uses as a basis for evaluating company performance, setting
incentive compensation targets, and planning and forecasting of future
periods. This information is not intended to be considered in isolation
or as a substitute for financial measures prepared in accordance with
GAAP. Tables that reconcile GAAP to non-GAAP disclosure follow:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MEAD JOHNSON NUTRITION COMPANY
|
|
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
|
|
(Dollars in millions, except per share data)
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR THE THREE MONTHS ENDED JUNE 30, 2012 and 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Before Interest
|
|
Net Earnings Attributable
|
|
Earnings per Common
|
|
|
|
and Income Taxes
|
|
to Shareholders
|
|
Share - Diluted
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
GAAP results
|
|
$
|
248.3
|
|
$
|
203.7
|
|
|
$
|
165.8
|
|
|
$
|
132.1
|
|
|
$
|
0.81
|
|
|
$
|
0.64
|
|
|
Specified Items:(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IT and other separation costs(2)
|
|
|
5.4
|
|
|
24.7
|
|
|
|
|
|
|
|
|
|
|
Severance and other costs(3)
|
|
|
0.5
|
|
|
(0.2
|
)
|
|
|
|
|
|
|
|
|
|
Legal, settlements and related costs(2,3)
|
|
|
1.4
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
Specified Items before income taxes
|
|
|
7.3
|
|
|
24.8
|
|
|
|
7.3
|
|
|
|
24.8
|
|
|
|
0.03
|
|
|
|
0.12
|
|
|
Income tax impact on items above
|
|
|
|
|
|
|
(1.9
|
)
|
|
|
(8.2
|
)
|
|
|
(0.01
|
)
|
|
|
(0.04
|
)
|
|
Non-GAAP results
|
|
$
|
255.6
|
|
$
|
228.5
|
|
|
$
|
171.2
|
|
|
$
|
148.7
|
|
|
|
0.83
|
|
|
|
0.72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)All Specified Items are included in the
Corporate and Other segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2)Included in Selling, General and
Administrative expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3)Included in Other Expenses/(Income)-net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOR THE SIX MONTHS ENDED JUNE 30, 2012 and 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Before Interest
|
|
Net Earnings Attributable
|
|
Earnings per Common
|
|
|
|
and Income Taxes
|
|
to Shareholders
|
|
Share - Diluted
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
GAAP results
|
|
$
|
497.1
|
|
$
|
426.3
|
|
$
|
330.0
|
|
|
$
|
278.2
|
|
|
$
|
1.61
|
|
|
$
|
1.35
|
|
|
Specified Items:(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IT and other separation costs(2)
|
|
|
7.1
|
|
|
40.1
|
|
|
|
|
|
|
|
|
|
Severance and other costs(3)
|
|
|
1.5
|
|
|
-
|
|
|
|
|
|
|
|
|
|
Legal, settlements and related costs(2,3)
|
|
|
2.9
|
|
|
1.2
|
|
|
|
|
|
|
|
|
|
Specified Items before income taxes
|
|
|
11.5
|
|
|
41.3
|
|
|
11.5
|
|
|
|
41.3
|
|
|
|
0.05
|
|
|
|
0.20
|
|
|
Income tax impact on items above
|
|
|
|
|
|
|
(2.9
|
)
|
|
|
(14.0
|
)
|
|
|
(0.01
|
)
|
|
|
(0.07
|
)
|
|
Non-GAAP results
|
|
$
|
508.6
|
|
$
|
467.6
|
|
$
|
338.6
|
|
|
$
|
305.5
|
|
|
$
|
1.65
|
|
|
$
|
1.48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)All Specified Items are included in the
Corporate and Other segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2)Included in Selling, General and
Administrative expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3)Included in Other Expenses/(Income)-net
|
|
|
|
|
|
|
|
|
|
|
|
|
Source: Mead Johnson Nutrition Company
Mead Johnson Nutrition Company
Investors: Kathy MacDonald,
(847) 832-2182, kathy.macdonald@mjn.com
Media:
Christopher Perille, (847) 832-2178, chris.perille@mjn.com